Literature DB >> 10894128

Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration.

G Cavaletti1, E Cavalletti, N Oggioni, C Sottani, C Minoia, M D'Incalci, M Zucchetti, P Marmiroli, G Tredici.   

Abstract

The distribution of paclitaxel (Taxol) within the central and peripheral nervous system after repeated administration of this antineoplastic agent is still largely unknown. In this study we determined for the first time paclitaxel tissue concentration in the brain, spinal cord, dorsal root ganglia (DRG) and sciatic nerve using an experimental paradigm in the rat which reproduces the features of paclitaxel peripheral neurotoxicity in humans. Pathological confirmation of the onset of paclitaxel-induced peripheral neurotoxicity was performed. In order to achieve reliable results even with low concentrations of paclitaxel, a newly reported analytical method (high-performance liquid chromatography with tandem mass spectrometry) was used. We demonstrated that paclitaxel has easy access to the DRG, where it accumulates, while the lowest concentrations of the drug were measured in the brain. The intermediate concentrations of paclitaxel observed in the sciatic nerve and spinal cord may be due to paclitaxel transport along the centrifugal and centripetal branches of the DRG neuron axons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894128

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  67 in total

1.  Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy.

Authors:  Haijun Zhang; Seo-Yeon Yoon; Hongmei Zhang; Patrick M Dougherty
Journal:  J Pain       Date:  2012-01-29       Impact factor: 5.820

Review 2.  Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

Authors:  Xiao-Min Wang; Tanya J Lehky; Joanna M Brell; Susan G Dorsey
Journal:  Cytokine       Date:  2012-04-24       Impact factor: 3.861

3.  Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings.

Authors:  Caraceni Augusto; Miccoli Pietro; Martini Cinzia; Curzi Sergio; Cresta Sara; Gianni Luca; Vidmer Scaioli
Journal:  J Neurooncol       Date:  2007-07-05       Impact factor: 4.130

4.  Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats.

Authors:  Annemarie Ledeboer; Brian M Jekich; Evan M Sloane; John H Mahoney; Stephen J Langer; Erin D Milligan; David Martin; Steven F Maier; Kirk W Johnson; Leslie A Leinwand; Raymond A Chavez; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2006-12-15       Impact factor: 7.217

5.  Chemotherapy-Induced Neurotoxicity: Evidence of a Protective Role of CC Homozygosis in the Interleukin-1β Gene-511 C>T Polymorphism.

Authors:  E Peila; F D'Agata; P Caroppo; L Orsi; P Mortara; S Cauda; M Manfredi; M M Caglio; P Fenoglio; B Baudino; G Castellano; G Bisi; L Pinessi; S Gallone
Journal:  Neurotox Res       Date:  2016-06-07       Impact factor: 3.911

6.  Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.

Authors:  Lin Li; Jinxiu Li; Yan Zuo; Danny Dang; Jeffrey A Frost; Qing Yang
Journal:  J Pain       Date:  2018-11-22       Impact factor: 5.820

7.  Increased α2δ-1-NMDA receptor coupling potentiates glutamatergic input to spinal dorsal horn neurons in chemotherapy-induced neuropathic pain.

Authors:  Youfang Chen; Shao-Rui Chen; Hong Chen; Jixiang Zhang; Hui-Lin Pan
Journal:  J Neurochem       Date:  2018-12-21       Impact factor: 5.372

8.  Increased spinal cord Na⁺-K⁺-2Cl⁻ cotransporter-1 (NKCC1) activity contributes to impairment of synaptic inhibition in paclitaxel-induced neuropathic pain.

Authors:  Shao-Rui Chen; Lihong Zhu; Hong Chen; Lei Wen; Geoffroy Laumet; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2014-09-24       Impact factor: 5.157

9.  Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.

Authors:  Krystyna M Wozniak; James J Vornov; Ying Wu; Kenichi Nomoto; Bruce A Littlefield; Christopher DesJardins; Yanke Yu; George Lai; Larisa Reyderman; Nancy Wong; Barbara S Slusher
Journal:  Cancer Res       Date:  2016-04-13       Impact factor: 12.701

10.  Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.

Authors:  Valentina A Carozzi; Alessia Chiorazzi; Annalisa Canta; Rena G Lapidus; Barbara S Slusher; Krystyna M Wozniak; Guido Cavaletti
Journal:  Neurotox Res       Date:  2009-09-15       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.